Canopy Growth Corp. analyst Pablo Zuanic on Monday cut his 12-month price target on Canopy Growth Corp. , to C$21 from C$30.50 on a lower sales outlook for the Canadian cannabis...
Investing.com – Canada equities were lower at the close on Friday, as losses in the Healthcare, Clean Technology and REITs sectors propelled shares lower. At the close in Toronto,...
Investing.com – Canada equities were higher at the close on Friday, as gains in the Materials, IT and Clean Technology sectors propelled shares higher. At the close in Toronto,...
Although we consider the United States to be the most attractive cannabis market in the world, we continue to remain bullish on the opportunity in the European Union (EU).
Canopy Growth Corporation revealed that its cannabis sales of CA$136 million ($108 million) did not reach a consensus of CA$151 million in the first three months of fiscal 2022.
Canopy Growth Corporation (CGC) has been an underperformer over the past 12 months.However, with the possibility of the federal legalization of cannabis in the United States, it...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Buy | Sell | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 515.00 | 515.00 | 515.00 | 0.00 | 0.00% | 0.00 | London | |||
| 5.95 | 5.95 | 5.95 | 0.00 | 0.00% | 27.09K | London | |||
| 378.30 | 388.00 | 376.20 | -1.90 | -0.50% | 685.90K | London | |||
| 43.00 | 44.30 | 40.80 | +3.00 | +7.50% | 3.74M | London | |||
| 61.50 | 62.30 | 60.50 | +0.50 | +0.82% | 341.48K | London | |||
| 290.60 | 291.00 | 279.40 | +13.40 | +4.83% | 2.60M | London | |||
| 1,992.00 | 2,020.00 | 1,974.00 | +4.0 | +0.20% | 23.95K | London | |||
| 0.525 | 0.00 | 0.00 | 0.000 | 0.00% | 277.38K | London | |||
| 336.55 | 337.50 | 330.35 | +6.05 | +1.83% | 43.50M | London | |||
| 1.62 | 1.62 | 1.62 | +0.12 | +8.33% | 5.60M | London | |||
| 7,554.00 | 7,916.00 | 7,554.00 | -272.0 | -3.48% | 522.14K | London | |||
| 147.48 | 148.40 | 135.74 | +14.98 | +11.31% | 140.63M | London | |||
| 5.30 | 5.30 | 5.30 | +0.45 | +9.09% | 4.42M | London | |||
| 0.63 | 0.00 | 0.00 | +0.0650 | +11.50% | 224.89M | London | |||
| 1,387.20 | 1,399.40 | 1,382.80 | -0.80 | -0.06% | 7.21M | London |
Canopy Growth Corp, formerly Tweed Marijuana Inc, is a Canada-based multi-brand cannabis company. The Company, through its subsidiaries Tweed Inc, Bedrocan Canada Inc, Tweed Farms Inc and Mettrum Health Corp is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.